BC
RDY icon

Brinker Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Brinker Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$435K Buy
+41,030
New +$417K 0.01% 746

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Brinker Capital's RDY Position: Q2 2020 in Review

Brinker Capital opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2020: 41,030 shares worth $435K. The stake represents 0.01% of the portfolio and ranks #746 among its holdings.

169 funds tracked by Wall St. Rank hold RDY as of Q2 2020.

  • Brinker Capital held 41,030 shares of Dr. Reddy's Laboratories worth $435K as of Q2 2020.
  • Dr. Reddy's Laboratories was a new Brinker Capital position in Q2 2020.
  • Dr. Reddy's Laboratories made up 0.01% of Brinker Capital's portfolio in Q2 2020, its #746 holding.
  • 169 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.